BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.630
+0.396 (17.73%)
At close: Apr 28, 2026, 4:00 PM EDT
2.603
-0.027 (-1.05%)
After-hours: Apr 28, 2026, 6:02 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $10.52 million as of April 28, 2026. Its market cap has decreased by -17.75% in one year.
Market Cap
10.52M
Enterprise Value
4.55M
1-Year Change
-17.75%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $10.52M, a decrease of -68.89%. That is a compound annual growth rate of -6.73%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 11.58M |
| Reviva Pharmaceuticals Holdings | 11.32M |
| Lunai Bioworks | 11.19M |
| Chemomab Therapeutics | 11.09M |
| Cellectar Biosciences | 11.07M |
| Imunon | 10.98M |
| Kiora Pharmaceuticals | 10.18M |
| Enveric Biosciences | 10.13M |